Documentation Centre

 

 

  of 411 Next page

Go to page: of

Screenshot Date Categories Title Author Format
High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The Lifelines Cohort Study. Metabolism. 2017;72:37-46 October 06, 2017 High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The Lifelines Cohort Study. Metabolism. 2017;72:37-46 Nass KJ, van den Berg EH, Faber KN, Schreuder TCMA, Blokzijl H, Dullaart RPF Key Publications
Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism. 2017;72:94-108 October 06, 2017 Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism. 2017;72:94-108 Reccia I, Kumar J, Akladios C, Virdis F, Pai M, Habib N, Spalding D Key Publications
What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? Int J Obes (Lond). 2017;41:853-865 October 03, 2017 What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? Int J Obes (Lond). 2017;41:853-865 Cuthbertson DJ, Steele T, Wilding JP, Halford JC, Harrold JA, Hamer M, Karpe F Key Publications
The influence of epicardial fat and nonalcoholic fatty liver disease on heart rate recovery in metabolic syndrome. Metab Syndr Relat Disord. 2017;15:226-232 September 19, 2017 The influence of epicardial fat and nonalcoholic fatty liver disease on heart rate recovery in metabolic syndrome. Metab Syndr Relat Disord. 2017;15:226-232 Cho KI, Jo EA, Cho SH, Kim BH Key Publications
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 2017;71:17-32. September 15, 2017 The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 2017;71:17-32. Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J et al. Key Publications
Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism. 2017;71:182-197 September 15, 2017 Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism. 2017;71:182-197 Doulberis M, Kotronis G, Gialamprinou D, Kountouras J, Katsinelos P Key Publications
Visceral-to-subcutaneous fat ratio is independently related to small and large cerebrovascular lesions even in healthy subjects. Atherosclerosis. 2017;259:41-45 September 06, 2017 Visceral-to-subcutaneous fat ratio is independently related to small and large cerebrovascular lesions even in healthy subjects. Atherosclerosis. 2017;259:41-45 Higuchi S, Kabeya Y, Kato K Key Publications
Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression. Metabolism. 2017;69:1-13 August 24, 2017 Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression. Metabolism. 2017;69:1-13 Singh RG, Yoon HD, Wu LM, Lu J, Plank LD, Petrov MS Key Publications
Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease. J Hypertens. 2017;35:737-744 August 21, 2017 Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease. J Hypertens. 2017;35:737-744 Lorbeer R, Bayerl C, Auweter S, Rospleszcz S, Lieb W, Meisinger C, Heier M, Peters A, Bamberg F, Hetterich H Key Publications
Hypertension and hepatic triglycerides content: a two (multi)-faceted clinical challenge? J Hypertens. 2017;35:715-717 August 18, 2017 Hypertension and hepatic triglycerides content: a two (multi)-faceted clinical challenge? J Hypertens. 2017;35:715-717 Perseghin G, Manzoni G, Grassi G Key Publications

  of 411 Next page

Go to page: of